Opko Health, Inc.

OPKO Health, Inc.'s next confirmed earnings release is scheduled for November 11, 2026.

As of June 30, 2026, OPKO Health, Inc. has 754.71M shares outstanding.

As of June 30, 2026, OPKO Health, Inc. maintains a current ratio of 3.35, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 33.62, indicating elevated leverage, while an interest coverage ratio of 0.92 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, OPKO Health, Inc. posted a negative return on equity (ROE) of -5.88, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -3.83, reflecting losses generated across the asset base. The company generates approximately 193,410.39 in revenue per employee across its workforce of 2,455.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 5.43 indicates how many times OPKO Health, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, OPKO Health, Inc. recorded an income tax benefit of -5.62M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -64.49M and -58.88M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on July 6, 2026, OPKO Health, Inc.'s stock has declined approximately 23.25% over the past 52 weeks.

Over the twelve months ended June 30, 2026, OPKO Health, Inc. generated 474.92M in revenue and converted that into -58.88M in net income, yielding earnings per share of -0.08. EBITDA reached 33.50M, while operating income came in at -135.63M.

As of June 30, 2026, OPKO Health, Inc. holds 242.96M in cash and equivalents against 321.58M in total debt, resulting in a net debt position of 39.01M. Total book value stands at 956.60M, with working capital of 283.44M providing operational flexibility.

OPKO Health, Inc. produced -99.67M in operating cash flow over the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, OPKO Health, Inc. posted a gross margin of 40.77, reflecting its pricing power and cost economics. The operating margin of -28.56 and net profit margin of -12.40 provide insight into operational efficiency.